TABLE 5.

A list of histone deacetylase inhibitors under different phases of clinical trial and their indication.

Histone acetyltransferase inhibitors
Classification	Compounds	Structure	Clinical stage	References
HDAC1/2i	MRLB-223		Preclinical	Newbold et al. (2013)
HDAC3i	BG45		Preclinical	Tang et al. (2018)
HDAC6i	Rocilinostat (ACY-1215)		clinical	Yang et al. (2020)
	Tubacin		Preclinical	Liang et al. (2019)
HDAC8i	C1A		Preclinical	Kaliszczak et al. (2013)
	HPOB		Preclinical	Liu et al. (2018)
	PCI-34051		Preclinical	Morgen et al. (2020)
	C149		Preclinical	Suzuki et al. (2012)